JP2007254348A - Inhibitor for preventing body fluid leakage for corpse and apparatus for treating corpse - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To obtain an inhibitor for preventing body fluid leakage for corpse, which is injected/packed into the body cavity of a corpse by an injection tool, brought into contact with a body fluid in the body cavity, quickly absorbs the body fluid, swells, is harden solidified and effectively prevents body fluid leakage and to provide an apparatus for treating a corpse, using the same. <P>SOLUTION: The inhibitor for preventing body fluid leakage for corpse is obtained by dispersing highly water-absorbing resin powder (C) into a liquid nonionic surfactant (A) to generate heat by mixing it with water and a dispersion stabilizer (B) such as a polyalkylene oxide-based thermoplastic nonionic water-absorbing resin, etc. The apparatus for treating a corpse is equipped with a cylindrical main body (20) having a discharge part (22) at the tip end and a collar part (26) projected to the outside in the radial direction for catching a finger on the rear end part and a syringe (10) having a piston (30) slidably inserted from the rear end part side into the cylindrical main body. The inhibitor (X) for preventing body fluid leakage is held inside the cylindrical main body. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

  The present invention relates to an oil jelly-like body fluid leakage preventing agent for preventing fluid leakage from a corpse by loading and sealing the body cavity such as mouth, nose, ear, anus, female vagina, etc. The present invention relates to a corpse treatment apparatus using the

  In general, after death of a human or animal, muscles in various parts of the body cavity are relaxed, and body fluids such as gastric fluid, lung fluid, ascites, and excreta are often leaked, causing malodor and infection by pathogenic bacteria. For this reason, for example, in hospitals, after confirming death, a large amount of gauze, absorbent cotton, etc. are loaded into body cavities such as the mouth, nose, ears, anus, and female vagina to prevent leakage of bodily fluids. Similar measures are also taken for the opening of the body after an accident or surgery. However, many of the operations for loading gauze, absorbent cotton, etc. into the body cavity are often performed by the hands of employees and nurses, etc., and at the same time the gauze, absorbent cotton, etc. have low water absorption capacity Therefore, there is a problem that body fluid often leaks during or after work, and there is a possibility of post-mortem infection due to this leaked substance during work, and there has been a strong demand for a solution.

  For this reason, it is known that high water-absorbent resin powder is loaded into the mouth, nose, ears, throat, etc. instead of gauze, absorbent cotton, etc. A method of loading a water-absorbent resin powder (see Patent Document 1), or a method of using a water-absorbent resin powder containing stabilized chlorine dioxide wrapped in a water-soluble sheet in the ear throat and nostril while the powder remains in the throat. Patent Document 2) is known. However, even if such a superabsorbent resin powder is to be loaded, it is difficult to load a narrow body cavity such as the throat and anus because of poor fluidity. Moreover, if it is only the entrance part of a nostril or an ear canal, such fine powder can be filled with an injector like a syringe, but it cannot be filled to the back. Also, if you try to fill while moving the injector to fill the depths, the fine powder that comes out of the tip will scatter and only dirty around the body.

  In recent years, it has been proposed to use jelly instead of powder in order to solve problems such as poor filling properties and workability of such a highly water-absorbent resin powder and scattering. A method using a powdered polymer dissolved in an appropriate amount of water and mixed appropriately to form a jelly (see Patent Document 3), or a method using an amphiphilic gel containing dimethylacrylamide as a main component (Patent Document 4) And a method using a high-water-absorbing polymer powder dispersed in a jelly containing alcohol as a main component (see Patent Document 5).

  A filling method for filling such a jelly-like body fluid leakage preventing agent in, for example, the throat of the nostril will be described with reference to FIG. 1. As described in Patent Document 5, a jelly-like body fluid leakage prevention agent is described. The injector 1 in which the agent 2 is accommodated has a piston 3 slidably inserted from the rear end thereof, and has an injection port 4 covered with a protective cap 5 at its tip, and is a film pack (not shown). ) Wrapped and sealed. The insertion tube 6 to be inserted into a body cavity such as the throat B has a connection portion 7 connected to the injection port 4 of the injector 1 at one end and an opening portion 8 inserted into the nostril A at the other end.

  Next, a method for using the corpse treatment apparatus prepared in this way will be described. In FIG. 1, A is a nostril, B is a throat part, C is a tongue, D is a trachea, E is an esophagus. At the time of use, the injector 1 is taken out from the film pack, the protective cap 5 of the inlet 4 of the injector 1 is removed, and the connecting portion 7 of the insertion tube 6 is fitted to the inlet 4 to connect the insertion tube 6. Next, the opening 8 of the insertion tube 6 is inserted from the nostril A toward the throat B, and the insertion is stopped when the stopper portion 9 of the insertion tube 6 hits the nose tip B. Then, the piston 3 of the injector 1 is pressed, and the jelly-like body fluid leakage preventing agent 2 in the injector 1 is injected into the throat B through the insertion tube 6. After the body fluid leakage preventing agent 2 in the injector 1 is extruded and filled, the injector 1 and the insertion tube 6 are removed from the nostril A.

The jelly-like body fluid leakage preventing agent as described above has a high fluidity and is easily filled even in a narrow body cavity such as a nostril or an ear canal, and has an advantage that it does not scatter even if it is press-fitted with an injector. In particular, in the case of a jelly in which a large number of highly water-absorbing polymer powders are dispersed, the water-absorbing performance is high, and it is possible to prevent the polymer from absorbing body fluid leaking from the body cavity and leaking to the outside. However, the conventional jelly-like body fluid leakage preventing agent has a problem in that the body fluid is likely to leak due to the relaxation of muscles in each part of the body cavity after death because the fluid absorption speed after infusion and loading into the body cavity with an infusion device is slow. Moreover, it cannot be said that it is sufficient in terms of liquid absorption capability immediately after injection / loading into a body cavity.
JP-A-10-298001 (Claims) JP-A-7-265367 (Claims) JP-A-8-133901 (Claims) JP 2001-288002 A (Claims) Japanese Patent No. 3586207 (Claims)

Accordingly, an object of the present invention is to inject and load a body fluid with a filling device and contact the body fluid within the body cavity to quickly absorb and swell and solidify the body fluid, effectively preventing body fluid leakage. The object is to provide a leakage prevention agent.
Another object of the present invention is to provide a corpse treatment apparatus that can inject and load such a humor leakage preventive agent into the body cavity of the corpse with good workability, and can effectively prevent humor leakage.

  In order to achieve the above object, according to the present invention, a nonionic surfactant (A) which is a liquid nonionic surfactant that generates heat when mixed with water, a polyalkylene oxide-based thermoplastic nonionic water-absorbing resin, and a copolymer of acrylic acid At least one dispersion stabilizer selected from the group consisting of a carboxyvinyl polymer of a copolymer, a carboxyvinyl polymer of an acrylic acid copolymer / alkali neutralizer, a lipophilic smectite, a synthetic hectorite, a natural hectorite, and a bentonite A body fluid leakage preventing agent is provided, wherein the superabsorbent resin powder (C) is dispersed in a viscous liquid base containing (B).

  In a preferred embodiment, the dispersion stabilizer (B) is a polyalkylene oxide-based thermoplastic nonionic water-absorbing resin. The body fluid leakage preventing agent of the present invention can further contain either or both of an alcohol-based organic solvent (D) and a thickener (E) that are soluble in water. -It can also contain at least 1 sort (s) chosen from the group which consists of antiseptic | preservative, a deodorizing agent, and a fragrance | flavor.

  Furthermore, according to the present invention, a cylindrical main body having a discharge port portion at the front end and a flange protruding outward in the radial direction for hooking a finger to the rear end portion, and the rear end side of the cylindrical main body from the rear end side. There is provided a treatment apparatus for a corpse comprising an injector having a piston that is slidably inserted, and wherein the bodily fluid leakage preventing agent is accommodated in the cylindrical main body.

  In a preferred aspect, the treatment apparatus is a treatment apparatus for injecting and loading the body fluid leakage preventing agent into the throat by inserting from the nostril, and further comprising a flexible synthetic resin insertion tube. The insertion tube is formed in a substantially hemispherical shape and has an opening on its side surface, and a rear end has a connection for connecting to the discharge port of the injector, Furthermore, it has a stopper portion protruding radially outward at a predetermined distance from the rear end.

  In another preferred aspect, the treatment device is a treatment device for injecting and loading the bodily fluid leakage preventing agent into the anus and / or vagina, wherein the discharge port portion at the distal end of the cylindrical main body has a radial direction. A plurality of tongue pieces curved and extended outward toward the center are formed into a substantially hemispherical shape, and an opening formed by an opening formed by the tips of the plurality of tongue pieces and a slit between the tongue pieces is formed. And a stopper portion projecting outward in the radial direction at a substantially middle portion of the cylindrical main body.

  Furthermore, according to the present invention, a corpse treatment device as a set is also provided, which treatment device is inserted through the nostril and injects and loads a bodily fluid leakage prevention agent into the throat, and an anus and / or It is characterized by comprising a treatment device for injecting and loading a bodily fluid leakage preventing agent into the vagina and a fiber sealing material for preventing bodily fluid leakage from the ear canal and / or nostril. The corpse treatment apparatus as the set preferably further includes a fiber sealing material for loading in the mouth.

  The body fluid leakage preventive agent of the present invention includes a liquid nonionic surfactant (A) that generates heat when mixed with water, a polyalkylene oxide-based thermoplastic nonionic water-absorbent resin, and a carboxy copolymer of acrylic acid. At least one dispersion stabilizer (B) selected from the group consisting of vinyl polymer, carboxyvinyl polymer of acrylic acid copolymer / alkali neutralizer, lipophilic smectite, synthetic hectorite, natural hectorite, and bentonite It is an oil jelly-like material in which a superabsorbent resin powder (C) is dispersed in a viscous liquid base that contains and is injected into and loaded into the body cavity of an corpse with an injection device, and contacts the body fluid in the body cavity Then, due to the exothermic action of the nonionic surfactant (A), the liquid-absorbing speed of the highly water-absorbent resin powder (C) is increased, and the fluid is rapidly absorbed and swollen. It will solidify to have stiff jelly (solid gel), whereby it is possible to perform anti fluid leakage effectively.

  According to a preferred aspect of the body fluid leakage preventing agent of the present invention, since the dispersion stabilizer (B) is a polyalkylene oxide-based thermoplastic nonionic water-absorbing resin, the high water absorption when contacting with body fluids. The uniform dispersion state of the conductive resin powder (C) can be more reliably maintained. Therefore, a bodily fluid leakage preventive agent containing a polyalkylene oxide thermoplastic nonionic water-absorbing resin as a dispersion stabilizer can absorb and swell fluid rapidly as a whole when injected and loaded into the body cavity. It can be solidified into a hard jelly with no property and prevent body fluid leakage more effectively. The body fluid leakage preventing agent of the present invention further contains either or both of water-soluble alcohol-based organic solvent (D) as an auxiliary solvent and thickener (E) for improving fluidity. Thus, the viscosity can be easily adjusted, the fluidity can be improved, and even a narrow body cavity such as the throat can be injected and loaded more smoothly. Furthermore, by containing at least one selected from the group consisting of bactericides, fungicides / antiseptics, deodorants and fragrances, these desired effects can also be exhibited.

  In addition, the corpse treatment apparatus of the present invention includes a cylindrical main body having a discharge port portion at the front end and a flange protruding outward in the radial direction for hooking a finger to the rear end portion, and a rear end of the cylindrical main body. An injector having a piston that is slidably inserted from the end side, and the body fluid leakage preventing agent is contained inside the cylindrical body, so that the body fluid leakage preventing agent is placed in the body cavity of the body In addition to exerting the effects described above when infused and loaded, and having a buttocks for hooking a finger to the rear end of the cylindrical main body, the operation of injecting the body fluid leakage preventing agent into the body cavity of the corpse is easier and easier to work with Can be done well.

  Further, in an aspect configured as a treatment device for injecting and loading the bodily fluid leakage prevention agent into the throat by inserting from the nostril, an operation of injecting the bodily fluid leakage prevention agent into the body cavity by having the buttocks In addition to the effect that it can be performed more easily and with good workability, the distal end portion of the flexible synthetic resin insertion tube is formed in a substantially hemispherical shape and has an opening portion on its side surface. The insertion tube can be inserted smoothly from the nostril to the throat, and it is difficult to inject the body fluid leakage prevention agent when the tip opening contacts the application site, like an insertion tube with an opening only at the tip. There is no such problem, and the body fluid leakage preventing agent can be injected and loaded smoothly. In addition, since it has a stopper that protrudes radially outward at a predetermined distance from the rear end of the insertion tube, the opening is always located at a fixed application site without requiring skill in inserting the insertion tube. Thus, the body fluid leakage preventing agent can be injected and loaded.

  On the other hand, in an aspect configured as a treatment device for injecting and loading the bodily fluid leakage preventing agent into the anus and / or vagina, the operation of injecting the bodily fluid leakage preventing agent into the body cavity by having the buttocks is easier. In addition to the effect that it can be performed with good workability, the discharge port portion at the tip of the cylindrical main body is formed in a substantially hemispherical shape by a plurality of tongue pieces that are curved and extended outward toward the center in the radial direction. In addition, since an opening formed by an opening formed by the tips of the plurality of tongue pieces and a slit between the tongue pieces is formed, the body fluid can be smoothly inserted into the anus and / or vagina and filled fluid prevention When the agent is pushed out by the piston, the bodily fluid leakage preventing agent pushes out the plurality of tongue pieces and also comes out from the slits between the spread tongue pieces, so that the surface area is increased. Therefore, when it comes into contact with the body fluid in the body cavity, it quickly absorbs liquid and becomes a solid gel without fluidity, and it becomes possible to prevent body fluid leakage more effectively and quickly. In addition, since it has a stopper part that protrudes radially outward in the substantially middle part of the cylindrical main body, it does not require skill in insertion, and an opening is always located at a fixed application site to inject and load a body fluid leakage prevention agent can do.

  Furthermore, the corpse treatment device as a set of the present invention includes a treatment device for injecting and loading a body fluid leakage preventing agent into the throat and injecting and loading a body fluid leakage preventing agent into the anus and / or vagina. And a fiber sealing material for preventing leakage of bodily fluid from the ear and / or nostril, and preferably also a fiber sealing material for loading in the mouth. Since it can comprise as a corpse treatment kit provided with all the required composition treatment tools, carrying around becomes easy and it becomes possible to perform corpse treatment more rapidly. Furthermore, by providing a fiber sealing material for preventing leakage of body fluid from the ear and / or nostril and a fiber sealing material for loading in the mouth, body fluid leakage due to relaxation of muscles in each part of the body cavity after death is further improved. It can be surely prevented.

  As a result of diligent research to solve the above-described conventional problems, the inventor generates heat when mixed with water, and quickly dissolves in the liquid nonionic surfactant (A) soluble in water. The oil jelly-like body fluid leakage preventing agent obtained by dispersing the superabsorbent resin powder (C) in the viscous liquid base containing the specific dispersion stabilizer (B) is the above-mentioned when the body fluid leaking contact agent is in contact with the body fluid. Due to the exothermic action of the nonionic surfactant (A), the liquid-absorbing speed of the highly water-absorbent resin powder (C) is increased, and the body fluid is quickly absorbed and swollen to solidify into a solid jelly with no fluidity. Thus, the inventors have found that the present invention has been completed.

  That is, since the water absorption rate of the highly water-absorbent resin powder (C) generally tends to increase as the temperature rises, the higher heat-absorbing resin powder (C) has a higher heat generation effect due to the exothermic action of the nonionic surfactant (A) when in contact with body fluid. The liquid absorption speed of the water absorbent resin powder (C) can be increased, and the body fluid can be rapidly absorbed and swollen to be solidified into a solid jelly having no fluidity. However, as the liquid absorption rate increases, the surface portion of the injected jelly-like material that comes into contact with the body fluid quickly solidifies into a solid jelly with no fluidity, so that the highly water-absorbent resin powder (C) is uniformly dispersed. Tends to collapse. Therefore, in the body fluid leakage preventing agent of the present invention, the above-mentioned specific dispersion stabilizer (B) that can absorb various electrolyte aqueous solutions and is hardly affected by the electrolyte concentration is further dissolved in the viscous liquid base, This maintains the uniform dispersibility of the superabsorbent resin powder (C). As a result, the body fluid leakage preventive agent of the present invention, when injected and loaded into the body cavity of an corpse with an injection device, quickly absorbs and swells as a whole and solidifies into a solid jelly with no fluidity, thereby preventing body fluid leakage. Can be carried out effectively.

  Nonionic surfactants (A) that generate heat when mixed with water used in the present invention and are liquid at room temperature include coconut oil fatty acid monoethanolamide, coconut oil fatty acid diethanolamide 1: 1 type, coconut oil fatty acid diethanolamide 1: Type 2, polyoxyethylene coconut oil fatty acid monoethanolamide, lauric acid diethanolamide, polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyethylene higher alcohol ether, polyethylene glycol (average molecular weight of polymerization degree is 600 or less) , Polyoxyethylene polyoxypropylene glycol (pluronic type nonionic surfactant obtained by adding ethylene oxide to polypropylene glycol), polyoxyethylene alkyl (alkyl group having 12 to 14 carbon atoms) ether (ethylene Examples include surfactants such as polyoxyethylene alkyl ether series, sorbitan fatty acid ester series, polyoxyethylene sorbitan fatty acid ester series, etc., such as the number of moles of oxide added: 7 to 12 moles. They can be used in combination. Among these nonionic surfactants (A), liquid polyethylene glycol (average molecular weight of polymerization degree is about 200 to 600) is preferable.

  These liquid nonionic surfactants (A), particularly liquid polyethylene glycol (average molecular weight of polymerization degree is about 200 to 600) are the above-mentioned dispersion stabilizers (B), especially polyalkylene oxide thermoplastic nonions. The mold water-absorbent resin powder can be easily dissolved at a low temperature (about 30 ° C. to 50 ° C.), and when mixed with water, as shown in Test Example 1 described later, it generates heat when it comes into contact with water. In addition, the water temperature rises (about 10 ° C to 12 ° C rises), and since it is a surfactant, it has good compatibility with water and can be easily mixed and dissolved with water to increase the water absorption rate of the superabsorbent resin as described above. It can quickly solidify into a solid jelly with no fluidity to prevent leakage of bodily fluids.

  The content of the nonionic surfactant (A) is preferably about 10 to 85% by mass, more preferably about 20 to 80% by mass, and further preferably about 30 to 70% by mass of the total amount of the body fluid leakage preventing agent. is there. When the content of the nonionic surfactant (A) exceeds 85% by mass, there is no problem with the dispersibility of the superabsorbent resin powder, but it is difficult to form a jelly and the liquid state is an aqueous solution. It is not preferable because it is close to. On the other hand, if the content of the nonionic surfactant (A) is too low, it is difficult to obtain a good jelly state.

The bodily fluid leakage preventive agent of the present invention may contain an anionic surfactant as needed in a quantitative ratio that does not impair the effects of the present invention, in addition to the nonionic surfactant (A). .
Examples of the anionic surfactant include polyoxyethylene alkyl ether sulfate, polyoxyethylene lauryl ether sodium sulfate, polyoxyethylene lauryl ether sulfate triethanolamine, polyoxyethylene alkyl (alkyl group having 11 to 15 carbon atoms) ether. Alkyl ether sulfates such as sodium sulfate (addition moles of ethylene oxide: 3) alkyl (carbon groups of alkyl groups 11, 13, 15) triethanolamine, sodium alkylsulfate, alkylsulfuric triethanolamine, higher alcohol sodium sulfate; Polyoxyethylene alkyl sulfosuccinate disodium, polyoxyethylene sulfosuccinate, polyoxyethylene sulfosuccinate disodium lauryl sulfonate, disodium lauryl sulfonate, sulfoco Surfactants such as sulfosuccinates such as polyoxyethylene lauryl ethanolamide disodium succinate; alkylbenzene sulfonates such as sodium dodecylbenzene sulfonate, and the like are used alone or in combination of two or more. Can do.

  The dispersion stabilizer (B) used in the present invention is for maintaining a uniform dispersion state of the superabsorbent resin powder, can absorb various electrolyte aqueous solutions, and is hardly affected by the electrolyte concentration. Oxide-based thermoplastic nonionic water-absorbent resin, carboxyvinyl polymer of acrylic acid copolymer, carboxyvinyl polymer / alkali neutralizer of acrylic acid copolymer, lipophilic smectite, synthetic hectorite, natural hectorite, And at least one selected from the group consisting of bentonite is used. Among these dispersion stabilizers (B), a polyalkylene oxide-based thermoplastic nonionic water-absorbing resin is preferable, and this resin can absorb various aqueous electrolyte solutions and is hardly affected by the electrolyte concentration. Absorption of alkaline aqueous solution is possible.

  The content of the dispersion stabilizer (B) is preferably about 0.5 to 40% by mass, more preferably about 1 to 30% by mass, based on the total amount of the body fluid leakage preventing agent. If the content of the dispersion stabilizer (B) is too low, it becomes difficult to maintain the uniform dispersibility of the superabsorbent resin powder. On the other hand, even if it is added in a large amount exceeding 40% by mass, the effect is further improved. Is not preferable from the viewpoint of economy.

  As the superabsorbent resin powder (C) used in the present invention, conventionally known superabsorbent resin powders can be used and are not limited to specific ones. Among them, polyvinyl acrylate, polyacrylic Acid salt, alginate, crosslinked acrylic acid graft copolymer, copolymer of vinyl alcohol and polyacrylic acid, polyethylene glycol polymer, polyacrylamide resin, copolymer of polyacrylic maleic acid, polyethylene oxide polymer , And at least one selected from the group consisting of polyalginate-based polymers can be suitably used.

The superabsorbent resin powder (C) is preferably a powder having an average particle size of about 18 mesh to 160 mesh (according to Tyler display), more preferably about 30 mesh to 140 mesh.
In addition, the content of the superabsorbent resin powder (C) must be a necessary amount to immediately absorb and expand the body fluid from the body without leaking from the body cavity to create a non-flowable gel. The content of the superabsorbent resin powder is preferably about 5 to 50% by mass, more preferably about 15 to 35% by mass, based on the total amount of the body fluid leakage preventing agent.

  The body fluid leakage preventive agent of the present invention includes, in addition to the above-described components, as necessary, a water-soluble alcohol-based organic solvent (D), or a thickener for further improving fluidity. (E) can also be contained.

As the alcohol-based organic solvent (D), any of the nonionic surfactants or polar solvents soluble in water can be used, and the solvent is not limited to a specific solvent, but includes ethylene glycol, propylene glycol, diethylene glycol, triethylene glycol. At least one alcohol-based organic solvent selected from the group consisting of glycerin, methyl alcohol, ethyl alcohol, and isopropyl alcohol can be suitably used. Among these alcohol solvents, glycerin is preferable. Glycerol easily mixes with water, but slightly increases the water temperature (about 3 ° C.) during mixing. Therefore, it is possible to increase the water absorption rate of the highly water-absorbent resin, increase the viscosity of the prepared body fluid leakage preventing agent, improve the fluidity, and contribute to preventing the oil jelly from coagulating at low temperatures.
The content of the alcohol organic solvent is preferably about 3 to 50% by mass, more preferably about 5 to 30% by mass, based on the total amount of the body fluid leakage preventing agent.

  The thickener (E) is not limited to a specific one, but at least one thickener selected from the group consisting of sodium carboxymethylcellulose, carboxymethylcellulose, methylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, sora gum, and sodium alginate. A viscous agent can be used suitably. The content of the thickener is preferably about 0.5 to 30% by mass, more preferably about 1 to 20% by mass, based on the total amount of the body fluid leakage preventing agent.

The body fluid leakage preventive agent of the present invention can further contain at least one of other additives such as bactericides, fungicides / preservatives, deodorants, and fragrances, if necessary.
Disinfectants include isopropylmethylphenol, chlorhexidine gluconate, thymol, o-phenylphenol, benzalkonium chloride, cetylpyridinium chloride, benzethonium chloride, triclosan, ε-polylysine, lysozyme chloride, hinokitiol, grapefruit seed extract, mustard extract A thing "Wasaolo" etc. are mentioned, These can be used individually or in combination of 2 or more types.

  Examples of the fungicides and preservatives include sodium paraoxybenzoate, butyl paraoxybenzoate, propyl paraoxybenzoate, isobutyl paraoxybenzoate, sodium benzoate, sodium propionate, thiabendazole, isothiazolone, etc. A combination of more than one species can be used.

  Deodorants include Moso bamboo extract, green tea extract, long-chain betaine compound, deodorant based on the generic type tannin of persimmon extract, plant-type special deodorant mixed with several plant extracts, etc. These can be used alone or in combination of two or more.

  Examples of the fragrances include various natural and artificial fragrances such as floral, citrus, fruity, woody, fresh note, mixed flavor, green and mint.

  The content of the fungicide, fungicide / preservative, deodorant and fragrance as described above maintains the desired effect of each component, and from the viewpoint of obtaining safety and good economic efficiency, the viscosity and fluidity are improved. The proportion of the whole body fluid leakage preventing agent is preferably about 0.001 to 15% by mass, more preferably about 0.003 to 8% by mass for the fungicide and the antifungal preservative, respectively. Similarly, the deodorant is preferably about 0.05 to 20% by mass, more preferably about 0.1 to 10% by mass. Moreover, it is preferable that a fragrance | flavor is about 0.001-10 mass%, More preferably, it is 0.01-5 mass%. In addition, it is also possible to add and contain a pigment, and it is not particularly limited, such as selection of the blending amount and color tone, and can be arbitrarily set.

The viscosity of the body fluid leakage preventive agent of the present invention containing the above components is preferably about 6,000 to 50,000 cPs, more preferably about 10,000 to 40 in order to have good fluidity. , 000 cPs.
In addition, the viscosity here uses a viscometer (manufactured by Brookfield, USA, “Digital Viscometer” model: DV-1 +), spindle No. Although it is the value measured on the measurement conditions of 07, rotation speed: 20rpm, use body fluid leakage prevention agent temperature: 20 degreeC, it is not limited to this, What is necessary is just the measurement value measured on the same conditions.
The lower the content of the nonionic surfactant (A), the higher the content of the superabsorbent resin powder (C), the shorter the time in which the bodily fluid leakage preventing agent becomes jelly-like, and the liquid Therefore, by adjusting the amount of these components, it is possible to adjust the liquid viscosity according to the time required for the jelly and the desired application (application site).

  The amount of the body fluid leakage preventing agent of the present invention injected and filled into the body cavity can be appropriately set according to the application site, and is not particularly limited. In addition, depending on the water absorption performance of the superabsorbent resin contained in the oil jelly-like body fluid leakage preventing agent, 3,000 ml of water is gelled and has a water absorption capability to prevent leakage of body fluid from inside the body cavity. It may be to some extent, generally 5 to 60 g is preferable, and more preferably 10 to 40 g. For example, the filling amount of the bodily fluid leakage preventive agent (containing 5 to 50% by mass of the superabsorbent resin) to be injected into the throat from the nostril of the corpse is preferably about 8 to 40 g, more preferably about 10 to 25 g. When the injection amount of the oil jelly-like body fluid leakage preventing agent is too large, the injection device becomes large, so that it is difficult to handle and the cost increases. On the other hand, when the injection amount is too small, it is difficult to harden the body fluid in a gel state, and there is a risk of the body fluid leaking out, which is not preferable.

Hereinafter, specific examples of each aspect of the corpse treatment apparatus of the present invention will be described with reference to the accompanying drawings.
2 to 5 show a treatment apparatus for injecting and loading the body fluid leakage preventing agent into the throat by inserting from the nostril. FIGS. 2 to 4 show the injector 10 and FIG. The pipe | tube 40 is shown and the code | symbol X has shown the bodily fluid leakage prevention agent of this invention accommodated in the injection device 10. FIG.

  2 to 4 show the injector 10, FIG. 4 shows a cross-sectional view of the state rotated by 90 ° around the center line from the state shown in FIG. 2. As shown in FIGS. 2 to 4, the injector 10 includes a cylindrical main body 20 and a piston 30 each made of a plastic such as high-density polyethylene, polyester, and polyamide. The cylindrical main body 20 includes a cylindrical member 21 having a discharge cylinder portion 22 that functions as a discharge port portion at the tip, and a cover member 25 that is crowned on the outer periphery thereof.

  As is clear from FIG. 2, the cover member 25 is a cylinder having an octagonal cross section. The cover member 25 is configured so that a nurse can easily discriminate it from a general syringe in a hospital, and the tip side is slightly tapered. It is formed in a tapered shape so that it does not easily fall off when the cylindrical member 21 is inserted. In addition, it is also possible to make it possible to clearly grasp the application place by coloring the cover member or coloring the cover member so that it is different from the color of other members to form a colorful injector. As clearly shown in FIG. 4, the cover member 25 has a pair of flange portions 26 protruding outward in the radial direction for hooking a finger to the rear end portion. The distal end portion of the collar portion 26 is curved in the direction of the discharge cylinder portion 22 so that the finger can be easily caught. Further, a pair of convex locking portions 23 are formed at the rear end of the cylindrical member 21, and when the collar portion 26 comes into contact with the locking portion 23, a finger is hooked on the collar portion 26 and injected. When the operation is performed, the cover member 25 is configured not to move backward from the rear end of the cylindrical member 21. Moreover, the protective cap 29 is removably crowned at the distal end opening of the discharge cylinder portion 22 after the body fluid leakage preventing agent of the present invention is filled in the injector 10. In this embodiment, the cylindrical member 21 and the cover member 25 are formed separately, but may be integrally formed.

  On the other hand, the piston 30 is slidably inserted into the cylindrical member 21 of the cylindrical main body 20 from the rear end side. The length of the piston 30 is designed to be longer than the length of the cylindrical member 21 so that the whole body fluid leakage preventing agent X of the contents can be pushed out. The piston 30 has a piston rod 31 having a cross-shaped cross section, and a circular flange portion 32 having a diameter slightly larger than the cross-sectional dimension of the piston rod is formed at the tip portion thereof. A gasket 34 made of synthetic resin, rubber or the like is crowned around the flange portion 33 formed so as to protrude from the circular flange portion 32. In addition, a disc-like portion 35 for touching the finger is formed at the rear end of the piston rod 31 so that the piston rod 31 can be easily pressed with the finger. When the piston 30 is inserted into the cylindrical member 21 of the cylindrical main body 20 from the rear end portion side, the piston 34 passes through the cylindrical member 21 with the gasket 34 in contact with the inner peripheral surface of the cylindrical member 21 of the injector 10. It is configured to slide. Further, a ring-shaped ridge portion 24 protruding slightly inward is formed on the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member 21, and the circular flange portion of the piston rod 31 is formed on the ridge portion 24. The piston 30 is configured not to easily come out of the cylindrical main body 20 when it hits 32. In this embodiment, the piston rod 31 has a cross-shaped cross section, but may have a rod shape such as a circular cross section.

  The insertion tube 40 is made of a flexible synthetic resin such as a polyester elastomer, a soft vinyl chloride resin, or a rubber having a flexibility of bending along the shape of the nasal cavity when inserted into the nostril. As shown in FIG. 5, the distal end portion 41 of the insertion tube 40 is formed in a substantially hemispherical shape so as to be easily inserted from the nostril and is closed, and on the side thereof, two positions shifted from each other are perpendicular to each other. In addition to having a pair of opening portions 42 in each direction, a tapered connection portion 43 that is slightly expanded on the rear side for connection to the discharge cylinder portion 22 of the injector 10 is provided at the rear end portion. In addition, a stopper section 44 having a circular cross section protruding outward in the radial direction so as to surround the outer periphery is provided at a position at a predetermined distance from the rear end of the insertion tube 40 (preferably the tip position of the connection portion 43).

  The opening 42 at the distal end of the insertion tube 40 can be a hole having a desired shape such as a circle or an ellipse, and the position is preferably a distance of about 5 to 30 mm from the distal end of the insertion tube. Moreover, although the number of the aperture parts 42 is four in this embodiment, it may be an arbitrary number of about 1 to 6. The stopper portion 44 determines the length (injection position) that the opening portion 42 reaches when the insertion tube main body is inserted into the pharynx through the nostril, but from the distal end of the insertion tube 40 to the stopper portion 44. Is preferably about 100 to 140 mm, and the outer diameter of the insertion tube body is preferably about 3.5 to 7 mm, and the inner diameter is preferably about 2 to 5 mm.

  In the above embodiment, the connection portion 43 is integrally formed at the rear end portion of the insertion tube 40, but the connection portion 43 may be a separate body. In this case, the connecting portion is preferably formed of a rigid synthetic resin, and the connecting portion and the insertion tube main body are joined by an appropriate means such as an adhesive or welding. Moreover, the stopper part 44 may be formed at the front end of the connection part, or may be formed at the rear end of the insertion tube. Furthermore, the insertion tube main body can be bent at a predetermined position from the distal end portion, and can be smoothly inserted without resistance when inserted from the nostril to the back of the pharynx. In this case, the bending position is preferably an arbitrary part having a distance of about 22 to 45 mm, more preferably about 20 to 30 mm from the distal end of the insertion tube main body, and the bending angle is preferably 0 to 95 °, more preferably. 30 to 70 °.

  When using the corpse treatment apparatus, first, the protective cap 29 of the discharge tube portion 22 of the injector 10 is removed, and the discharge tube portion 22 is fitted into the connection portion 43 of the insert tube 40 to connect the insert tube 40 and the injector 10. Connecting. Next, the insertion tube 40 is inserted from the nostril A (see FIG. 1) toward the throat B, and the insertion is stopped when the stopper portion 44 of the insertion tube 40 hits the tip of the nose. At this time, a lubricant may be applied to the insertion tube 40 in order to reduce the insertion resistance. Then, the piston 30 of the injector 10 is pressed, and the jelly-like body fluid leakage preventing agent X in the injector 10 is injected into the throat B through the insertion tube 40. After the body fluid leakage preventing agent X in the injector 10 is extruded and filled, the injector 10 and the insertion tube 40 are extracted from the nostril A.

  In the above operation method, the insertion tube 40 is inserted into the nostril A while being connected to the injector 10, but the insertion tube 40 is first inserted into the nostril A, and then the injector 10 is connected to the insertion tube 40. Also good. Further, the injector 10 and the insertion tube 40 may be stored in a container in a connected state, and in this case, the treatment work can be performed immediately after being taken out from the container. Alternatively, in the above-described embodiment, the injector 10 and the insertion tube 40 are separate bodies, but they may be integrally manufactured. Further, even if a mark is provided instead of the stopper portion 44 formed on the insertion tube 40, variations in the insertion position can be prevented to some extent.

Next, a preferred embodiment of a treatment apparatus for injecting and loading the body fluid leakage preventing agent into the anus and / or vagina will be described with reference to FIGS.
6 to 8 show the injector 10a. FIG. 8 shows a cross-sectional view of the injector 10a rotated by 90 ° around the center line from the state shown in FIG. As shown in FIGS. 6 to 8, also in this embodiment, the injector 10a includes a cylindrical main body 20a made of a plastic such as high-density polyethylene, polyester, polyamide, etc. And a piston 30. However, unlike the above-described embodiment, a fibrous filler (plug member) Y is housed in the injector 10a together with the jelly-like body fluid leakage preventing agent X. This fibrous filler Y has a gap between the gel in the body cavity of the anus and vagina after the jelly-like body fluid leakage preventing agent X becomes a solid gel, and the muscles in each part of the body cavity relax after death. In order to prevent the body fluid from leaking out even if this occurs, the contents can be limited to the jelly-like body fluid leakage preventing agent X only. The amount of the body fluid leakage preventing agent X (containing 5 to 50% by mass of the superabsorbent resin) contained in one device is about 1 to 10 g, more preferably about 1 to 5 g, and the length of the fibrous filler Y is about It is preferable to set the diameter within a range of 10 to 30 mm and a diameter of about 8 to 23 mm.

  The cylindrical main body 20a includes a cylindrical member 21a having a discharge port portion 22a at the tip, and a cover member 25a covered with an outer periphery thereof. The discharge port portion 22a at the tip of the cylindrical member 21a is formed in a substantially hemispherical shape by a plurality of tongue pieces 28 that are curved and extended outward toward the center in the radial direction. An opening is formed from the opening of the part and a slit between the tongue pieces. Each tongue piece 28 has flexibility so that it can be bent outward. If a cylindrical syringe (syringe) with a large outer diameter is inserted into the anus or vagina after the death until it stiffens, the anal canal and the ostium of the vagina will open widely and it will take time to contract, which may cause fluid leakage. Become. Further, the thinner the cylindrical member 21a, the easier it is to insert and the easier it is to use. Accordingly, the outer diameter of the cylindrical member 21a is preferably set within a range of about 10 to 25 mm, more preferably about 10 to 15 mm, and the inner diameter is set within a range of about 8 to 23 mm.

  As is clear from FIG. 6, the cover member 25a is a cylinder having an octagonal cross section, and is configured so that a nurse can easily distinguish it from a general syringe in a hospital. In addition, it is also possible to make it possible to clearly grasp the application place by coloring the cover member or coloring the cover member so that it is different from the color of other members to form a colorful injector. As clearly shown in FIG. 8, the cover member 25a has a cap-shaped stopper portion 27 that expands rearward at the front end portion thereof, and projects outward in the radial direction for hooking a finger to the rear end portion. The pair of flange portions 26 is provided. The distance from the tip of the cylindrical member 21a to the stopper portion 27 is preferably set within a range of about 15 to 50 mm, and the height of the stopper portion 27 from the outer peripheral surface of the cylindrical member 21a is easily set to the anus or vagina. It is preferable to set within a range of about 5 to 30 mm so as to stop at the mouth. The stopper portion 27 is not necessarily required to have a cap shape as in this embodiment, and a member that can ensure that no further insertion is performed at a position where the injector 10 is inserted into the anus or vagina by a predetermined length. Alternatively, it may be a mark, for example, a disk shape, or a mark that can be easily visually confirmed. Further, the distal end portion of the collar portion 26 is curved in the direction of the discharge port portion 22a so that the finger can be easily caught. It is preferable that the height of the collar portion 26 from the outer peripheral surface of the cylindrical member 21a is set within a range of about 5 to 18 mm, and the degree of curvature of the tip portion is within a range of 0 to 50 °. When such a cover member is used, the above-described collar portion and the stopper portion may be provided at predetermined positions of the cover member. Preferably, as in the present embodiment, the stopper portion is the tip of the cover member or the cover member. When the length is the same as that of the cylindrical member, it is desirable to provide the substantially intermediate portion and the collar portion at the rear end portion of the cover member.

  Further, a pair of convex locking portions 23 are formed at the rear end of the cylindrical member 21a, and when the collar portion 26 comes into contact with the locking portions 23, a finger is hooked on the collar portion 26 and injected. When the operation is performed, the cover member 25a is configured not to move backward from the rear end of the cylindrical member 21a. Further, the protective cap 29a is removably crowned at the tip of the cylindrical member 21a after the injector 10 is filled with the bodily fluid leakage preventing agent of the present invention. Also in this embodiment, the cylindrical member 21a and the cover member 25a are formed separately, but may be integrally formed.

  On the other hand, the structure of the piston 30 is the same as that of the above embodiment, and is slidably inserted into the cylindrical member 21a of the cylindrical main body 20a from the rear end side. The length of the piston 30 is designed to be longer than the length of the cylindrical member 21a so that the body fluid leakage preventing agent X and the fibrous filler Y of the contents can all be pushed out. The piston 30 has a piston rod 31 having a cross-shaped cross section, and a circular flange portion 32 having a diameter slightly larger than the cross-sectional dimension of the piston rod is formed at the tip portion thereof. A gasket 34 made of synthetic resin, rubber or the like is crowned around the flange portion 33 formed so as to protrude from the circular flange portion 32. In addition, a disc-like portion 35 for touching the finger is formed at the rear end of the piston rod 31 so that the piston rod 31 can be easily pressed with the finger.

  When the piston 30 is inserted into the cylindrical member 21a of the cylindrical main body 20 from the rear end side, the piston 30 passes through the cylindrical member 21a with the gasket 34 in contact with the inner peripheral surface of the cylindrical member 21a of the injector 10. It is configured to slide. Furthermore, a ring-shaped ridge 24 protruding slightly inward is formed on the inner peripheral surface in the vicinity of the rear end portion of the cylindrical member 21a, and the circular flange portion of the piston rod 31 is formed on the ridge 24. The piston 30 is configured not to easily come out of the cylindrical main body 20 when it hits 32. In this embodiment, the piston rod 31 has a cross-shaped cross section, but may have a rod shape such as a circular cross section.

  When using the treatment device for injecting and loading the body fluid leakage preventing agent X and the fibrous filler Y into the anus and / or vagina, first, the protective cap 29a of the discharge port 22a of the injector 10a is not removed. For example, it is inserted into the anus or vagina as it is, and the insertion is stopped when the stopper portion 27 hits the outside of the anus or vagina. At this time, a lubricant may be applied to the protective cap 29a in order to reduce insertion resistance. Then, the piston 30 of the injector 10a is pressed, and the jelly-like body fluid leakage preventing agent X and the fibrous filler Y in the injector 10a are injected together with the protective cap 29a. At that time, the superabsorbent resin powder in the bodily fluid leakage preventing agent X that has absorbed the bodily fluid and the liquid in the filth swells, and part of it penetrates into the fibrous filler Y and becomes a solid gel. The body fluid and filth can be effectively prevented from leaking out. Thereafter, the injector 10a is extracted from the anus and vagina.

  The fibrous filler Y is a non-woven fabric of superabsorbent resin fiber, compressed pulp paper, cotton, cotton and superabsorbent resin fiber blend, molded product of superabsorbent resin fiber, synthetic fiber nonwoven fabric, cloth, etc. In particular, Runseal (registered trademark) F or Runseal (registered trademark) K manufactured by Toyobo Co., Ltd., which is composed of an inner layer of water-swellable fiber, for example, an acrylic fiber and an outer layer made of a water-absorbing resin, is formed into a cylindrical shape. It is preferable to use a molded product or a product obtained by compression-molding pulp into a cylindrical shape (eg, a female tampon type).

  A treatment apparatus for injecting and loading a bodily fluid leakage prevention agent into the throat by inserting through the nostril as described above, and a treatment apparatus for injecting and loading the bodily fluid leakage prevention agent into the anus and / or vagina include an ear hole and It is preferable that the body treatment apparatus unit is configured to be housed in one container together with a fiber sealing material for preventing leakage of body fluid from the nostril, or a fiber sealing material for loading in the mouth, As a result, it is convenient to carry and the body can be treated quickly.

Fiber sealing material for preventing leakage of body fluids from the ear and nostrils is made of cotton, superabsorbent resin fibers, blends of cotton and superabsorbent resin fibers, and non-woven fabrics. What was shape | molded in this shape can be used suitably. It is preferable to provide two sealants for earplugs and two sealants for nasal plugs.
Also, the fiber sealing material for loading in the mouth is intended to be placed in the cheek to prevent leakage of bodily fluids and to form the bulge of the cheek in the direction close to the natural bulge. , Cotton and superabsorbent resin fiber blend, cloth or non-woven fabric such as superabsorbent resin fiber, or non-woven fabric of cotton and superabsorbent resin fiber, or a sandwich of these single component members in any layer structure The sealing material which consists of the member laminated | stacked on can be used suitably.

  As mentioned above, although the preferable specific example of each aspect of the corpse treatment apparatus of this invention was demonstrated referring an accompanying drawing, the oil jelly-like bodily fluid leakage prevention agent of this invention is the mouth of a corpse with a conventionally well-known injector, Needless to say, it can be injected and loaded into a body cavity such as the nose, ear, anus, or vagina of a woman and sealed, and is not limited to the above-described embodiments.

Examples and test examples in which the effects of the body fluid leakage preventing agent of the present invention are specifically confirmed are shown below, but the present invention is of course not limited to the following examples.
Test Example 1 (Exothermic temperature measurement test of test material)
Test method:
10 g of each raw material shown in Table 1 was weighed into a 30 ml beaker, and then the exothermic temperature of the mixed solution when 8 g of ion-exchanged water was injected was measured under the following conditions.
Measuring instrument: Temperature sensor for liquid of DATA COLLECTOR manufactured by Anritsu Keiki Co., Ltd.
Room temperature at the time of measurement: 22.3 ° C.
The test results are also shown in Table 1.

上記表１に示すように、液状のノニオン性界面活性剤であるＰＥＧ２００の場合、水と混和すると直ちに発熱し、速やかに水に可溶となり、またその温度レベルをある程度の時間維持できた。これに対して、アルコール系溶剤である無水グリセリン、エチレングリコール、エチルアルコールの場合、水と混和した後に僅かに発熱するが、その温度レベルがかなり低く、またその温度レベルも維持できない。このことから、液状のノニオン性界面活性剤であるＰＥＧ２００は、高吸水性樹脂の吸水速度を高め、速やかに流動性の無い固いゼリー状に固化して体液漏出防止を図る体液漏出防止剤の基剤として最適であることがわかる。

As shown in Table 1 above, in the case of PEG200, which is a liquid nonionic surfactant, heat was generated immediately when mixed with water, and it quickly became soluble in water, and the temperature level could be maintained for a certain period of time. In contrast, anhydrous glycerin, ethylene glycol, and ethyl alcohol, which are alcohol solvents, generate a slight amount of heat after being mixed with water, but the temperature level is quite low and the temperature level cannot be maintained. Therefore, PEG200, which is a liquid nonionic surfactant, is a body fluid leakage preventing agent that increases the water absorption rate of the highly water-absorbent resin and quickly solidifies into a solid jelly with no fluidity to prevent fluid leakage. It turns out that it is optimal as an agent.

Examples 1 to 3 and Comparative Examples 1 and 2
In the blending ratio shown in Table 2, a highly water-absorbent resin powder is uniformly dispersed in a solution obtained by dissolving a nonionic water-absorbing resin having a polyalkylene oxide thermoplasticity in a nonionic surfactant (polyethylene glycol 200). A body fluid leakage preventing agent was prepared (Examples 1 to 3). For comparison, the superabsorbent resin powder is uniformly dispersed in a solution in which an acrylic acid polymer (carboxyvinyl polymer / alkali neutralizer) as a gelling agent is dissolved in ethylene glycol, which is an alcohol solvent. Thus, a body fluid leakage preventing agent was prepared (Comparative Examples 1 and 2).
The water absorption rate and state of the body fluid leakage preventing agents prepared in this way were compared by the following test methods.

Test example 2 (test sample water absorption rate test)
Test method:
1 g of a test sample was weighed into a 100 ml beaker, and then 80 ml of ion exchange water (20 ° C.) was injected, and the time until all of the ion exchange water became jelly was measured.
The test results are shown in Table 2. In Table 2, “%” means “mass%”.

上記表２に示す結果から明らかなように、高吸水剤樹脂粉末の添加量が１０質量％と同じでも、基剤としてエチレングリコールを用いた比較例２の場合にはゼリー状にならなかったのに対し、液状のノニオン性界面活性剤であるＰＥＧ２００を用いた実施例３ではゼリー状にすることができた。また、比較例２では、高吸水剤樹脂粉末を均一に分散させるのに５５分を要し、しかも液の状態はシャボシャボの水溶液であった。このことから、アルコール系の基剤を用いた場合、体液漏出防止剤の調製にも長時間を要し、作業性が悪いことがわかる。さらに、高吸水剤樹脂粉末の添加量が２０質量％と同じでも、基剤としてエチレングリコールを用いた比較例１の場合には、ゼリー状になるまでの時間が５１０秒と長かったのに対し、ＰＥＧ２００を用いた実施例１では１０２秒でゼリー状にすることができた。このことから、本発明の体液漏出防止剤は、速やかに流動性の無い固いゼリー状に固化して体液漏出防止を図る体液漏出防止剤として最適であることがわかる。

As is apparent from the results shown in Table 2 above, even when the amount of the superabsorbent resin powder added was the same as 10% by mass, it did not become a jelly in Comparative Example 2 using ethylene glycol as the base. On the other hand, in Example 3 using PEG200 which is a liquid nonionic surfactant, it was able to be made into a jelly form. In Comparative Example 2, 55 minutes were required to uniformly disperse the highly water-absorbent resin powder, and the liquid state was an aqueous solution of a shabo-shabo. From this, it is understood that when an alcohol base is used, it takes a long time to prepare the body fluid leakage preventing agent and the workability is poor. Furthermore, even when the amount of the superabsorbent resin powder added was the same as 20% by mass, in the case of Comparative Example 1 using ethylene glycol as the base, the time until the jelly was long was 510 seconds. In Example 1 using PEG200, it was possible to form a jelly in 102 seconds. From this, it can be seen that the body fluid leakage preventing agent of the present invention is optimal as a body fluid leakage preventing agent that quickly solidifies into a solid jelly having no fluidity to prevent body fluid leakage.

It is a schematic sectional drawing which shows the use condition of the conventional corpse treatment apparatus. 1 shows one embodiment of a corpse treatment apparatus according to the present invention, in which (A) is a front view, (B) is a left side view, and (C) is a right side view. It is a longitudinal cross-sectional view along the center axis line of the corpse treatment apparatus shown in FIG. It is a cross-sectional view along the central axis of the corpse treatment apparatus shown in FIG. It is a longitudinal cross-sectional view which shows the insertion tube of the corpse treatment apparatus which concerns on this invention. The other embodiment of the corpse treatment apparatus which concerns on this invention is shown, (A) is a front view, (B) is a left view, (C) is a right view. It is a longitudinal cross-sectional view along the center axis line of the corpse treatment apparatus shown in FIG. It is a cross-sectional view along the central axis of the body treatment apparatus shown in FIG.

Explanation of symbols

1, 10, 10a Syringe 20, 20a Cylindrical body 21, 21a Cylindrical member 22, 22a Discharge port (discharge cylinder)
23 Locking portion 24 Projection portion 25, 25a Cover member 26 Gutter portion 27, 44 Stopper portion 28 Tongue piece 29, 29a Protective cap 30 Piston 31 Piston rod 32 Circular flange portion 33 Flange portion 34 Gasket 35 Disc-shaped portion 40 Insertion Tube 42 Opening part 43 Connection part X Fluid leakage preventive agent Y Fibrous filler A Nostril B Throat part C Tongue D Trachea E Esophageal

Claims (9)

  Liquid nonionic surfactant (A) that generates heat when mixed with water, polyalkylene oxide thermoplastic nonionic water-absorbent resin, carboxyvinyl polymer of acrylic acid copolymer, carboxy of acrylic acid copolymer A viscous liquid base containing at least one dispersion stabilizer (B) selected from the group consisting of vinyl polymer / alkali neutralizer, lipophilic smectite, synthetic hectorite, natural hectorite, and bentonite; A body fluid leakage preventive agent comprising a superabsorbent resin powder (C) dispersed therein.   The body fluid leakage preventing agent according to claim 1, wherein the dispersion stabilizer (B) is a polyalkylene oxide-based thermoplastic nonionic water-absorbing resin.   The body fluid leakage preventing agent according to claim 1 or 2, further comprising one or both of an alcohol-based organic solvent (D) and a thickener (E) soluble in water.   The body fluid leakage preventing agent according to any one of claims 1 to 3, further comprising at least one selected from the group consisting of bactericides, fungicides / preservatives, deodorants and fragrances. .   A cylindrical main body having a discharge port at the front end and a flange protruding outward in the radial direction for hooking a finger to the rear end, and slidably inserted into the cylindrical main body from the rear end side. A body treatment apparatus, comprising: a syringe having a piston, wherein the body fluid leakage preventing agent according to any one of claims 1 to 4 is housed in the cylindrical main body.   A treatment device for injecting and loading the body fluid leakage preventing agent into the throat by inserting from the nostril, further comprising a flexible synthetic resin insertion tube, the distal end of the insertion tube being substantially hemispherical And has an opening on the side surface thereof, a rear end portion having a connection portion for connection to the discharge port portion of the injector, and a radial direction at a predetermined distance from the rear end. The treatment apparatus according to claim 5, further comprising a stopper portion protruding outward.   A treatment apparatus for injecting and loading the bodily fluid leakage preventing agent into the anus and / or vagina, wherein a plurality of tongues are formed such that a discharge port portion at the distal end of the cylindrical main body is curved outward and extends toward the radial center. An opening formed by an opening formed by a plurality of tongue pieces and a slit between the tongue pieces is formed in a substantially hemispherical shape by the piece, and in an approximately middle portion of the cylindrical main body. The treatment apparatus according to claim 5, further comprising a stopper portion protruding outward in the radial direction.   The treatment apparatus for injecting / loading a body fluid leakage preventing agent into the throat by inserting through the nostril according to claim 6 and the body fluid leakage preventing agent injecting / loading into the anus and / or vagina according to claim 7 A corpse treatment device comprising: a treatment device for performing a treatment, and a fiber sealing material for preventing leakage of bodily fluid from the ear canal and / or nostril.   The treatment device according to claim 8, further comprising a fiber sealing material for loading in the mouth.

Images